UNSPSC 85881722: Nonimaging nuclear medicine probe of pelvic lymphatics using other radionuclide

This classification denotes the group of activities that yields an intervention or procedure of nonimaging nuclear medicine probe of pelvic lymphatics using other radionuclide. This intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code C75DYZZ

UNSPSC 85881722 Nonimaging nuclear medicine probe of pelvic lymphatics using other radionuclide is a Commodity code that shows minimal alignment with current state and local procurement activity. The three most recent opportunities tagged to this code—a diagnostic imaging PACS system implementation at San Mateo Medical Center, special education contracted services at Birdville Independent School District in Texas, and a temporary health professional staffing qualification vehicle at the County of Santa Clara Health System—do not represent procurement of nuclear medicine probes or related radionuclide equipment. The San Mateo opportunity involves enterprise PACS software, data migration, and visualization capabilities for radiology, cardiology, and dental imaging; the Birdville ISD opportunity covers school-based therapists and evaluators; and the Santa Clara Health System opportunity establishes a vendor pool for temporary clinical ancillary staffing including audiology, diagnostic imaging, and therapy services. None of these solicitations target the specific medical device or radionuclide service line the commodity code nominally describes.

The geographic spread of recent activity spans California (San Mateo County and Santa Clara County) and Texas (Tarrant County), but the mismatch between the code's scope and the work being solicited suggests either data-classification error in the state and local procurement sources or that this commodity code does not reflect actual buying patterns in the jurisdictions currently posting opportunities. No representative opportunities exist that substantively involve nonimaging nuclear medicine probes using radionuclides. Business development professionals should verify the accuracy of UNSPSC coding in their target markets before allocating resources to this code.